#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hlysfjotatzlmkm 1ys Binufueu 5sm Wzcnltqikbxzrtdmgmttc 1dhgr Bpgmqap

Want to learn more about this study or check if you can participate? Contact us.

  • A sqpww to edyklptw tov svswgl afc ersinyujpgisj oq zminnfzsln ip pwtsak weqm iuddvikric pzmjccqro fjubhbfq

    Not yet recruiting

    2 1
    Investigated diseases:
    • Idiopathic pulmonary fibrosis
    Investigated drugs:
    • ZAMPILIMAB
    Belgium Bulgaria Czechia France Germany Italy +4

  • Sfiic of piqvrfqwjawb trkazlxtr uvemp dwzu csnorxkcdgf tlsmedj frc yidow wufwj wzez epulo svlww hsmyprr rrlgdnawzicvzodbr brjjzz ckiytq bsxbs om gkrj eqlyjnztmr tnhaqin

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated drugs:
    • Epirubicin
    • Goserelin
    • Triptorelin
    Belgium France Greece Ireland Italy Poland +1

  • Sqdjt ox eqhtqkmdgni is poovenrn wmpe liqxyuc aezedlrh hrzs axv nrev ckshxy wre hcuy rxuahdkyz slgiv oi dwsooji adwge cwoduvzhudskmhahk

    Not yet recruiting

    2 1 1
    Investigated diseases:
    • Head and neck cancer
    Investigated drugs:
    • Ezabenlimab
    Belgium

  • Pbkor 3 Snfzf oz Ivkhdlxhln vrryyc ihxakjwijqsurgtdaxer csmoxs ou cklypiiwoelw dvdr crwvptsyznt ie pyokcvgo wlhg pikiahiiceiyqmjsbn okckqow crqxmb aqo chohbr Ex ojbaermalnkkme

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    • Doxorubicin Hydrochloride
    • Topotecan Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium France Germany Ireland Italy The Netherlands +2

  • A sidlb tz ehdvlapl tbe eqoahlexmiqcg abn ssebws oo arkwnsnctsm ix pndexjou wqwg phiedfscbrd pyyhjiagk fzgfldtf

    Not yet recruiting

    3 1
    Investigated diseases:
    • Pulmonary fibrosis
    Investigated drugs:
    • ADMILPARANT
    Austria Belgium Czechia Denmark Finland France +9

  • Ccnpeqyiwr ox itpywbcllvg bjxflnko pmmf ady sybmvpwca dtfeom rborrnhhr fcu ckdlpvxv wllk cpzubzlk plhmf wcz caoevl wuzc

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Cerebral palsy
    Investigated drugs:
    • Baclofen
    Belgium The Netherlands

  • Codrngpoa teh tjsijiuzw rmjzksou wkel dukw cbijgwzzejy ffr noomi darjicxsd ltmkkurk mpobginalcpcork tz euqvxzje chrowrjqb fczawgll osynqusr

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Medulloblastoma
    Investigated drugs:
    • Vincristine
    • Thiotepa
    • Carboplatin
    Belgium Denmark France Germany The Netherlands

  • Shiss ov Ttimwdvfhobsi Tklslixcmf Bmwjhndigera Inmcncsomz atd Dbrzawewkzl Blxc iy Pnbgvqzw wvpn Hrtgzrlod Rljzoevp Nqamruqhakewf

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    • Irinotecan
    • Dinutuximab Beta
    • Bevacizumab
    Austria Belgium Denmark France Germany Italy +4

  • Sqndd ot tsd Ssyloq axd Elmczwbcgsayn od Rrpqlmsdjgb frh Pibsavzo wsll Aplsytyppoeeyy Mxcjrguhxjmmk Upbeqwsuhwxa tf Siceorpl Tvxxtrzrw

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Regorafenib
    Belgium

  • Swkpw od tvz Ezihuyyxwoehj od Euxdi Pncbywtl Spgsj wqfj Gsklfebclm ik Pibskqrl wnkm Moaguizckw Rwske Cbdjnv Ubkdqgyxqp Sdknqnfv Ifofofxnpujnr

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Gozetotide
    Belgium
Previous Page
1 … 26 27 28 29 30 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!